Brasada Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-24,853
Closed -$2.79M 144
2024
Q3
$2.79M Buy
24,853
+1,971
+9% +$234K 0.49% 65
2024
Q2
$2.95M Buy
22,882
+506
+2% +$65.2K 0.51% 59
2024
Q1
$2.95M Buy
22,376
+4,646
+26% +$573K 0.52% 56
2023
Q4
$1.93M Sell
17,730
-1,004
-5% -$104K 0.37% 72
2023
Q3
$1.96M Buy
18,734
+1,936
+12% +$209K 0.46% 58
2023
Q2
$1.94M Sell
16,798
-213
-1% -$24.2K 0.42% 61
2023
Q1
$1.81M Buy
+17,011
New +$1.84M 0.4% 61
2019
Q1
Sell
-218
Closed -$16K 217
2018
Q4
$16K Sell
218
-87
-29% -$6.14K 0.01% 217
2018
Q3
$21K Buy
+305
New +$19.4K 0.01% 238

Other funds holding MRK

Brasada Capital Management's MRK Position: Q4 2024 in Review

Brasada Capital Management sold out of Merck (MRK) in Q4 2024, closing a stake of 24,853 shares — an estimated $2.79M sold.

Brasada Capital Management first reported a position in MRK in Q3 2018 and held it in 9 quarters. The position peaked at $2.95M in Q1 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Brasada Capital Management reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Brasada Capital Management sold 24,853 Merck shares in Q4 2024, an estimated $2.79M.
  • Brasada Capital Management first reported a position in Merck in Q3 2018 and held it in 9 quarters.
  • Brasada Capital Management's Merck position peaked at $2.95M in Q1 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Brasada Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.